Publications by authors named "Xiang-Yan Jiang"

Inflammatory arthritis leads to peripheral nerve sensitization, but the therapeutic effect is often unsatisfactory. Our preliminary studies have found that in mice with inflammatory arthritis, the use of ionotropic glutamate receptor antagonists can produce a good analgesic effect without altering foot swelling, suggesting that pain relief may be related to the improvement of neuropathic pain. However, the underlying mechanisms remain unclear.

View Article and Find Full Text PDF

Background: Pancreatic ductal adenocarcinoma (PDAC) remains a treatment-refractory malignancy with poor prognosis. It is urgent to identify novel and valid biomarkers to predict the progress and prognosis of PDAC. The S100A family have been identified as being involved in cell proliferation, migration and differentiation progression of various cancer types.

View Article and Find Full Text PDF

Background: Gastric cancer (GC) is one of the most globally prevalent cancers in the world. The pathogenesis of GC has not been fully elucidated, and there still lacks effective targeted therapeutics. The influence of altered kinesin superfamily protein 22 (KIF22) expression in GC progression is still unclearly.

View Article and Find Full Text PDF
Article Synopsis
  • A meta-analysis was conducted to assess if injecting hCG into the uterus before embryo transfer (ET) enhances outcomes in women undergoing IVF-ET.
  • The study included 15 randomized controlled trials with 2,763 participants, comparing results between those who received the hCG injection and those who did not.
  • Results showed that women who received the hCG injection had significantly higher rates of live births, ongoing pregnancies, clinical pregnancies, and implantation, along with a lower miscarriage rate, suggesting that hCG injections improve IVF-ET success.
View Article and Find Full Text PDF

Src homolog and collagen homolog (Shc) proteins have been identified as adapter proteins associated with cell surface receptors and have been shown to play important roles in signaling and disease. Shcbp1 acts as a Shc SH2-domain binding protein 1 and is involved in the regulation of signaling pathways, such as FGF, NF-κB, MAPK/ERK, PI3K/AKT, TGF-β1/Smad and β -catenin signaling. Shcbp1 participates in T cell development, the regulation of downstream signal transduction pathways, and cytokinesis during mitosis and meiosis.

View Article and Find Full Text PDF